Literature DB >> 2022167

Protooncogenes and growth factors associated with normal and abnormal liver growth.

N Fausto1.   

Abstract

Hepatocyte replication during liver regeneration depends on extrinsic (circulating) and intrinsic (intrahepatic) factors. Two important growth factors produced in the regenerating liver are discussed, TGF alpha, an autocrine, stimulatory growth factor, and TGF beta, a paracrine inhibitory factor. The balance between the activities of these factors is likely to play an important role in regulating hepatocyte proliferation. The expression of some protooncogenes occurs sequentially during the first few hours after partial hepatectomy and is a marker for the entry of hepatocytes into the cell cycle (proliferative competence). As hepatocytes become competent to proliferate, they respond to TGF alpha and other growth factors and enter a proliferative phase. It is possible that TGF beta 1 serves as a stop signal for liver regeneration but the mechanisms by which TGF beta inhibits hepatocyte DNA synthesis are still unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2022167     DOI: 10.1007/bf01297034

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

Review 1.  Regulation of liver growth: protooncogenes and transforming growth factors.

Authors:  N Fausto; J E Mead
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

Review 2.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

3.  Sequential protooncogene expression during rat liver regeneration.

Authors:  N L Thompson; J E Mead; L Braun; M Goyette; P R Shank; N Fausto
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

Review 4.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

Review 5.  Transforming growth factors.

Authors:  A B Roberts; M B Sporn
Journal:  Cancer Surv       Date:  1985

6.  Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.

Authors:  B I Carr; I Hayashi; E L Branum; H L Moses
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

7.  Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs.

Authors:  A Francavilla; P Ove; L Polimeno; M Coetzee; L Makowka; J Rose; D H Van Thiel; T E Starzl
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

8.  Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers.

Authors:  R Turner; R Tjian
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

9.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor.

Authors:  K Miyazawa; H Tsubouchi; D Naka; K Takahashi; M Okigaki; N Arakaki; H Nakayama; S Hirono; O Sakiyama; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

10.  Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects.

Authors:  L Braun; P Gruppuso; R Mikumo; N Fausto
Journal:  Cell Growth Differ       Date:  1990-03
View more
  5 in total

Review 1.  Biology of the adult hepatic progenitor cell: "ghosts in the machine".

Authors:  Houda Darwiche; Bryon E Petersen
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  From Autonomy to Integration, From Integration to Dynamically Balanced Integrated Co-existence: Non-aging as the Third Stage of Development.

Authors:  Lev Salnikov; Mamuka G Baramiya
Journal:  Front Aging       Date:  2021-03-25

3.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

4.  Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers.

Authors:  S Tanaka; K Takenaka; T Matsumata; R Mori; K Sugimachi
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

5.  Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.

Authors:  Mohammad R Ebrahimkhani; Fiona Oakley; Lindsay B Murphy; Jelena Mann; Anna Moles; Maria J Perugorria; Elizabeth Ellis; Anne F Lakey; Alastair D Burt; Angela Douglass; Matthew C Wright; Steven A White; Fabrice Jaffré; Luc Maroteaux; Derek A Mann
Journal:  Nat Med       Date:  2011-11-27       Impact factor: 53.440

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.